Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EX Other antiglaucoma preparations
S01EX06 Omidenepag
D10966 Omidenepag isopropyl (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D10966 Omidenepag isopropyl (JAN)
Drug groups [BR:br08330]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG02831 Omidenepag
D10966 Omidenepag isopropyl
Metabolizing enzyme substrate
DG02970 CES substrate
DG03241 CES1 substrate
DG02831 Omidenepag
D10966 Omidenepag isopropyl
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D10966 Omidenepag isopropyl
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostaglandin
PTGER2
D10966 Omidenepag isopropyl (JAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10966
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10966
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10966
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10966
Drug groups [BR:br08330]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG02831 Omidenepag
Metabolizing enzyme substrate
DG02970 CES substrate
DG03241 CES1 substrate
DG02831 Omidenepag